Emerging evidence also suggests potential cardiovascular benefits, with some injectable GLP-1 receptor agonists demonstrating reduced risk of major adverse cardiovascular events in people with established cardiovascular disease
Mol Biol Evol 27, 395407, doi: 10.1093/molbev/msp251 (2010)
In: Gopalakrishnakone P., Cruz L., Luo S
The reduced incretin effect of GIP in diabetic subjects may be due to the down-regulation of GIP receptor expression, which has been found in pancreatic islets of diabetic Zucker rats and reverted following correction of hyperglycemia [35]
If side effects are severe or do not improve after a few days, contact your provider
Medical oversight: Warning signs to watch for: The FDA has also updated warnings for medications like Ozempic to include the risk of ileus (a blockage in the intestines)